Five competencies for operational excellence in cell and gene therapy clinical trials

April 5, 2021

What is different about cell & gene therapy trials, and what does it take to operationalize them effectively? In this article, Operations and Regulatory experts from Parexel Biotech break it down into five competencies you need for success.

Previous Article
The impact of COVID-19 on clinical trials in rare disease and oncology
The impact of COVID-19 on clinical trials in rare disease and oncology

Next Article
Three ways to improve your chances that insurers will pay for a new CGT
Three ways to improve your chances that insurers will pay for a new CGT

When developing cell and gene therapies (CGTs), drug companies face significant hurdles. One of which is ge...